5 g/d group was

provided with six GPLC capsules. Participants were directed to take their six capsule daily supplements approximately 90 minutes prior to exercise on training days and to take the six capsules with breakfast on other days. The GPLC used in this study was the USP grade nutritional product, GlycoCarn™ (Sigma Ta Health Sciences, S.p.A., Rome, Italy), a molecularly bonded form of glycine and propionyl-L-carnitine. Assessment Protocol The testing protocol used in the present investigation is consistent with that previously described by these investigators (Jacobs, 2009). Briefly, this CP868596 testing protocol included five high intensity stationary cycle sprints, each sprint 10-NSC 683864 ic50 seconds in duration with 1-minute active recovery periods. Sprints were performed with a Monarch 894E leg ergometer (Monarch, Varberb, Sweden) with the external applied resistance equivalent to 7.5% of each subject’s body mass. Ten minutes of unloaded pedalling at 60 RPM was performed as a warm-up prior to the sprint testing. The 1-minute

recovery periods were active with unloaded pedalling with cadence fixed at 60 RPM. Anaerobic power output was measured using the SMI OptoSensor 2000 (Sports Medicine Industries, Inc., St. Cloud, Minn). Power output variables included peak power (PP) which was determined as the power output established during the first 5 seconds of each ten second sprint; and mean power (MP) which was the power output measured during the full ten seconds of each Fludarabine mouse sprint. The third power output variable was a power decrement (DEC) which was calculated as the difference in power output between the first 5 seconds and the second five seconds

of each sprint, as expressed as a percentage of the first 5 second period. Heart rate (HR) was determined using a Polar HR monitoring system with HR values assessed at rest, during the final five seconds of each sprint bout, as well as four and fourteen minutes after the final sprint bout. Blood lactate levels (LAC) were assessed using the Accutrend® lactate analyzer (Sports Resource BCKDHA Group, Inc., Pleasantville, NY). Calibration procedures were performed prior to each testing session using standard control solutions. Blood lactate levels were determined at rest as well as four and fourteen minutes post exercise. Net lactate accumulation per unit power output was calculated as (LAC14-LACrest)·(MPave)-1. Thigh girth of the dominant leg was measured using a Gulick tape at 15 mm superior to the patella while in a standing position with weight shifted onto the non-dominant leg. Thigh girth measurements were taken at rest and four minutes after the final sprint bout. Statistical Analyses A repeated measures general linear model was used to examine for differences in outcome measures between groups (1.5 g/d, 1 g/d, 4.5 g/d), conditions (pre- and post-GPLC) and across time. Measures of power output (PP, MP, DEC) were determined across time during each of the five successive sprint bouts.